Regulation of hepatic schemia/reperfusion injury by gene transfer and its usefulness of prevention for organ failure

基因转移对肝缺血/再灌注损伤的调节及其预防器官衰竭的作用

基本信息

  • 批准号:
    15591382
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Hepatic ischemia/reperfusion injury is a clinically important problem. While the mechanisms of the initial event and subsequent neutrophil-dependent injury are somewhat understood, little is known with respect to regulation of endogenous hepatoprotective effect on this injury. IL-12 plays a role in the induction of this injury, but involvement of IL-18 has not been clarified. Using a murine model of partial hepatic ischemia (subjected to 90 minutes) and subsequent reperfusion, the aim of the current study was to determine whether IL-18 is upregulated during hepatic ischemia/reperfusion and to determine the role of endogenous IL-18 in the development and regulation of inflammatory hepatic ischemia/reperfusion injury. Hepatic IL-18 expression was upregulated from 1 to 8 hours after reperfusion. Hepatic ischemia/reperfusion induced NF-κB and AP-1 activation as defined by electrophoretic mobility shift assay, and caused significant increases in liver neutrophil recruitment, apoptosis, hepatocellular injury, and liver edema as defined by liver myeloperoxidase content, TUNEL staining, serum aminotransferase levels, and liver wet to dry weight ratios, respectively. In mice treated with neutralizing antibody to IL-18,ischemia/reperfusion-induced increases in CXC chemokine expression, activation of NF-κB and AP-1,and apoptosis were greatly reduced. Furthermore, under blockade of IL-18, anti-inflammatory cytokmes such as IL-4 and IL-10 were greatly upregulated. Transcriptional factor, STAT6,was significantly activated under blockade of IL-18. These conditions also caused significant reduction in liver neutrophil sequestration and liver injury. In conclusion, the data suggest that IL-18 is required for facilitating neutrophil-dependent hepatic ischemia/reperfusion injury through suppressing anti-inflammatory cytokine expression.
肝缺血/再灌注损伤是临床上的一个重要问题,虽然对初始事件和随后的中性粒细胞依赖性损伤的机制有所了解,但对于内源性肝保护作用在这种损伤中的作用知之甚少。这种损伤的诱导,但尚未阐明 IL-18 的参与,使用部分肝缺血(经历 90 分钟)和随后的再灌注的小鼠模型。本研究的目的是确定IL-18在肝缺血/再灌注过程中是否上调,并确定内源性IL-18在炎症性肝缺血/再灌注损伤的发生和调节中的作用。肝脏IL-18表达从1上调。根据电泳迁移率变化测定,肝脏缺血/再灌注诱导 NF-κB 和 AP-1 激活,并导致肝脏显着增加。在用 IL-18 中和抗体治疗的小鼠中,中性粒细胞募集、细胞凋亡、肝细胞损伤和肝水肿分别通过肝髓过氧化物酶含量、TUNEL 染色、血清转氨酶水平和肝脏湿重与干重比来定义。诱导的 CXC 趋化因子表达增加、NF-κB 和 AP-1 激活以及细胞凋亡大大减少。此外,在 IL-18 阻断下, IL-4 和 IL-10 等抗炎细胞因子在 IL-18 的阻断下显着上调。数据表明,IL-18 是通过抑制抗炎细胞因子表达促进中性粒细胞依赖性肝缺血/再灌注损伤所必需的。

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kimura F, Yoshidome H, Miyazaki M, et al.: "Partial splenic embolization for the treatment of hereditary spherocytosis."AJR Am J Roentgenol.. 81. 1021-1024 (2003)
Kimura F、Yoshidome H、Miyazaki M 等人:“部分脾栓塞治疗遗传性球形红细胞增多症。”AJR Am J Roentgenol.. 81. 1021-1024 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Surgical treatment for extrahepatic recurrence after hepatectomy for colorectal metastases.
结直肠转移肝切除术后肝外复发的手术治疗。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshidome H;Kimura F;Kato A;Miyazaki M. et al.
  • 通讯作者:
    Miyazaki M. et al.
Yoshidome H, Miyazaki M, et al.: "Surgical Treatment for Extrahepatic Recurrence after Hepatectomy for Colorectal Metastases."Hepatogastroenterology. (in press).
Yoshidome H、Miyazaki M 等人:“结直肠转移肝切除术后肝外复发的手术治疗。”肝胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kitayama D, Yoshidome H, Miyazaki M, et al.: "Aggressive Surgical Resection for Hepatocellular Carcinoma with Tumor Thrombus Extending to Inferior Vena Cava and Synchronous Pulmonary Metastasis."Hepatogastroenterology. (in press).
Kitayama D、Yoshidome H、Miyazaki M 等人:“肿瘤血栓延伸至下腔静脉和同步性肺转移的肝细胞癌的积极手术切除。”肝胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Should the Inferior Vena Cava be Reconstructed after Resection for Malignant Turners?
恶性特纳病切除后是否需要重建下腔静脉?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIDOME Hiroyuki其他文献

YOSHIDOME Hiroyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIDOME Hiroyuki', 18)}}的其他基金

A new perspective for extending use of steatotic liver graft by analyzing for phosphorylation signaling pathway and applying for endothelial progenitor cells.
通过分析磷酸化信号通路并应用于内皮祖细胞,为扩大脂肪变性肝移植的应用提供了新的视角。
  • 批准号:
    22591500
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation for gene transfer regulation of organ failure induced by hepatic ischemia/reperfusion injury
肝缺血/再灌注损伤所致器官衰竭的基因转移调控研究
  • 批准号:
    17591371
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic Investigation of Regulation of Hepatic Ischemia and Reperfusion Injury and Promotion of Hepatic Regeneration
肝脏缺血再灌注损伤调控及促进肝脏再生的机制研究
  • 批准号:
    13671282
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

转录调节因子NcoR1抑制肝移植缺血再灌注损伤的作用和机制研究
  • 批准号:
    82060126
  • 批准年份:
    2020
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
HSF1通过抑制小胶质细胞XBP1/NLRP3/caspase-1信号通路改善脑缺血再灌注损伤的机制研究
  • 批准号:
    81901192
  • 批准年份:
    2019
  • 资助金额:
    20.5 万元
  • 项目类别:
    青年科学基金项目
单核细胞特异性转录因子ATF3作为抑炎枢纽抵抗心肌缺血再灌注损伤的分子机制
  • 批准号:
    81970215
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
心肌缺血再灌注损伤的调控新分子——BTF
  • 批准号:
    81903614
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female Heart
压力会阻碍雌激素对女性心脏的抗氧化保护,从而加剧心肌缺血性损伤
  • 批准号:
    10715407
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Targeting Ischemia/Reperfusion Stress to Inhibit Cytomegalovirus Reactivation After Lung Transplant
针对肺移植后缺血/再灌注应激抑制巨细胞病毒再激活
  • 批准号:
    10453246
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Engineering Human Heart Tissues with Polyploid Cardiomyocytes
用多倍体心肌细胞改造人类心脏组织
  • 批准号:
    10616611
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Regulation and interplay of Heat Shock Factors in growth-associated proteotoxic stresses
生长相关蛋白毒性应激中热休克因子的调节和相互作用
  • 批准号:
    10693802
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了